The impact of administration of tranexamic acid in reducing the use of red blood cells and other blood products in cardiac surgery
about
Getting it right: optimizing transfusion management during the procedureThe role of tranexamic acid in reducing blood loss in total knee replacement.Ecallantide (DX-88), a plasma kallikrein inhibitor for the treatment of hereditary angioedema and the prevention of blood loss in on-pump cardiothoracic surgery
P2860
The impact of administration of tranexamic acid in reducing the use of red blood cells and other blood products in cardiac surgery
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The impact of administration o ...... od products in cardiac surgery
@ast
The impact of administration o ...... od products in cardiac surgery
@en
The impact of administration o ...... od products in cardiac surgery
@nl
type
label
The impact of administration o ...... od products in cardiac surgery
@ast
The impact of administration o ...... od products in cardiac surgery
@en
The impact of administration o ...... od products in cardiac surgery
@nl
prefLabel
The impact of administration o ...... od products in cardiac surgery
@ast
The impact of administration o ...... od products in cardiac surgery
@en
The impact of administration o ...... od products in cardiac surgery
@nl
P2093
P2860
P921
P356
P1433
P1476
The impact of administration o ...... od products in cardiac surgery
@en
P2093
Alain Vuylsteke
Caroline Gerrard
Fay Cafferty
Palanikumar Saravanan
P2860
P2888
P356
10.1186/1471-2253-6-9
P407
P577
2006-08-30T00:00:00Z
P5875
P6179
1020431957